Director at National Healthcare (NYSE: NHC) granted 7,500 options

Rhea-AI Filing Summary

National Healthcare Corp director Lisa Piercey received a grant of stock options as compensation. On May 7, 2026, she was awarded options to purchase 7,500 shares of common stock at an exercise price of $171.42 per share, expiring on May 6, 2030. The options were granted under the company’s 2020 Omnibus Equity Incentive Plan, with no cash paid at grant, and leave her holding 7,500 options following the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Piercey Lisa

Role null

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock [2026 Grant]	7,500	$0.00	--

Holdings After Transaction: Option to Purchase Common Stock [2026 Grant] — 7,500 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 7,500 options Exercise price: $171.42 per share Expiration date: May 6, 2030 +2 more

5 metrics

Options granted 7,500 options Stock options to purchase common stock granted May 7, 2026

Exercise price $171.42 per share Conversion or exercise price of granted options

Expiration date May 6, 2030 Option expiration date for this grant

Options after transaction 7,500 options Total derivative securities following the transaction

Grant price paid $0.00 per option Transaction price per option at grant

Key Terms

Option to Purchase Common Stock, 2020 Omnibus Equity Incentive Plan, Rule 16b-3(d), Section 16(b), +1 more

5 terms

Option to Purchase Common Stock financial

"security_title: Option to Purchase Common Stock [2026 Grant]"

2020 Omnibus Equity Incentive Plan financial

"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan"

Rule 16b-3(d) regulatory

"exempt from Section 16(b) pursuant to Rule 16b-3(d)"

Section 16(b) regulatory

"The grant and exercise of these stock options are exempt from Section 16(b)"

A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.

derivative securities financial

"derivativeTransactionCount: 1, total derivative securities following the transaction"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Piercey Lisa

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock [2026 Grant]	$171.42	05/07/2026		A		7,500(1)		05/07/2026	05/06/2030	Common Stock	7,500	$0	7,500	D

Explanation of Responses:

1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

	/s/ Lisa Piercey	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did NHC director Lisa Piercey report on her latest Form 4?

Lisa Piercey reported a grant of stock options from National Healthcare Corp. She received options for 7,500 shares of common stock as part of equity compensation, rather than buying or selling shares in the open market, under the company’s 2020 Omnibus Equity Incentive Plan.

How many National Healthcare Corp (NHC) options did Lisa Piercey receive?

Lisa Piercey received 7,500 stock options linked to National Healthcare Corp common shares. These options give her the right to buy up to 7,500 shares at a fixed exercise price, providing potential future ownership if she chooses to exercise them before the stated expiration date.

What is the exercise price and term of Lisa Piercey’s NHC stock options?

The options have an exercise price of $171.42 per share and expire on May 6, 2030. This means she can purchase National Healthcare Corp common stock at $171.42 any time before that date, subject to the plan’s vesting and exercise conditions disclosed elsewhere.

Was Lisa Piercey’s NHC option grant an open-market purchase or compensation award?

The transaction was a compensation-related award, not an open-market purchase. It is coded as a grant or award acquisition under Form 4 rules, showing options issued at no cost at grant, consistent with equity incentives provided under the 2020 Omnibus Equity Incentive Plan.

How many National Healthcare Corp options does Lisa Piercey hold after this grant?

Following this transaction, Lisa Piercey holds 7,500 stock options reported for National Healthcare Corp. The filing shows total derivative securities following the transaction equal to 7,500 options, all directly owned, reflecting her position under the company’s equity incentive arrangements.